Satoshi UEHA

Person

Tokyo, JP

People

Patents Grantslast 30 patents

Information Patent Grant
HMGN partial peptide and cancer therapy using the same
- Patent number 11,919,932
- Issue date Mar 5, 2024
- The University of Tokyo
- Kouji Matsushima
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HMGN partial peptide and cancer therapy using the same
- Patent number 11,572,393
- Issue date Feb 7, 2023
- The University of Tokyo
- Kouji Matsushima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for reducing side effects of immune checkpoint control agent
- Patent number 11,168,137
- Issue date Nov 9, 2021
- IDAC THERANOSTICS, INC.
- Satoru Ito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for assessing therapeutic effect of anti-cancer agent having...
- Patent number 10,746,726
- Issue date Aug 18, 2020
- The University of Tokyo
- Kouji Matsushima
- G01 - MEASURING TESTING
Information Patent Grant
Prophylactic and/or therapeutic agent for radiation damage
- Patent number 9,895,331
- Issue date Feb 20, 2018
- The University of Tokyo
- Tohru Tanaka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunological reconstitution promoter or prophylactic agent for inf...
- Patent number 9,156,912
- Issue date Oct 13, 2015
- The University of Tokyo
- Kouji Matsushima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HMGN PARTIAL PEPTIDE AND CANCER THERAPY USING THE SAME
- Publication number 20230220022
- Publication date Jul 13, 2023
- THE UNIVERSITY OF TOKYO
- Kouji MATSUSHIMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HMGN PARTIAL PEPTIDE AND CANCER THERAPY USING THE SAME
- Publication number 20200407408
- Publication date Dec 31, 2020
- THE UNIVERSITY OF TOKYO
- Kouji MATSUSHIMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENT FOR SOLID CANCER
- Publication number 20190125867
- Publication date May 2, 2019
- IDAC Theranostics, Inc.
- Satoru ITO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR ASSESSING THERAPEUTIC EFFECT OF ANTI-CANCER AGENT HAVING...
- Publication number 20170328887
- Publication date Nov 16, 2017
- THE UNIVERSITY OF TOKYO
- Kouji MATSUSHIMA
- G01 - MEASURING TESTING
Information Patent Application
THERAPEUTIC AGENT FOR SOLID CANCER
- Publication number 20170165364
- Publication date Jun 15, 2017
- IDAC Theranostics, Inc.
- Satoru ITO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR REDUCING SIDE EFFECTS OF IMMUNE CHECKPOINT CONTROL AGENT
- Publication number 20170145099
- Publication date May 25, 2017
- IDAC Theranostics, Inc.
- Satoru ITO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR RADIATION DAMAGE
- Publication number 20150190356
- Publication date Jul 9, 2015
- The University of Tokyo
- Tohru Tanaka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOLOGICAL RECONSTITUTION PROMOTER OR PROPHYLACTIC AGENT FOR INF...
- Publication number 20120027748
- Publication date Feb 2, 2012
- Kouji Matsushima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prevention and treatment for GVHD
- Publication number 20060233710
- Publication date Oct 19, 2006
- Kouji Matsushima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Satoshi UEHA

Person

Patents Grantslast 30 patents

HMGN partial peptide and cancer therapy using the same

HMGN partial peptide and cancer therapy using the same

Method for reducing side effects of immune checkpoint control agent

Method for assessing therapeutic effect of anti-cancer agent having...

Prophylactic and/or therapeutic agent for radiation damage

Immunological reconstitution promoter or prophylactic agent for inf...

Patents Applicationslast 30 patents

HMGN PARTIAL PEPTIDE AND CANCER THERAPY USING THE SAME

HMGN PARTIAL PEPTIDE AND CANCER THERAPY USING THE SAME

THERAPEUTIC AGENT FOR SOLID CANCER

METHOD FOR ASSESSING THERAPEUTIC EFFECT OF ANTI-CANCER AGENT HAVING...

THERAPEUTIC AGENT FOR SOLID CANCER

METHOD FOR REDUCING SIDE EFFECTS OF IMMUNE CHECKPOINT CONTROL AGENT

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR RADIATION DAMAGE

IMMUNOLOGICAL RECONSTITUTION PROMOTER OR PROPHYLACTIC AGENT FOR INF...

Prevention and treatment for GVHD